|
1
|
Mitrou P, Lambadiari V, Maratou E, et al:
Skeletal muscle insulin resistance in morbid obesity: the role of
interleukin-6 and leptin. Exp Clin Endocrinol Diabetes.
119:484–489. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Oakley RH and Cidlowski JA: The biology of
the glucocorticoid receptor: new signaling mechanisms in health and
disease. J Allergy Clin Immunol. 132:1033–1044. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Deroo BJ and Archer TK: Glucocorticoid
receptor-mediated chromatin remodeling in vivo. Oncogene.
20:3039–3046. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nelson G, Wilde GJ, Spiller DG, et al:
NF-kappaB signalling is inhibited by glucocorticoid receptor and
STAT6 via distinct mechanisms. J Cell Sci. 116:2495–2503. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Segard-Maurel I, Rajkowski K, Jibard N,
Schweizer-Groyer G, Baulieu EE and Cadepond F: Glucocorticosteroid
receptor dimerization investigated by analysis of receptor binding
to glucocorticosteroid responsive elements using a monomer-dimer
equilibrium model. Biochemistry. 35:1634–1642. 1996. View Article : Google Scholar
|
|
6
|
Adcock IM and Caramori G: Cross-talk
between pro-inflammatory transcription factors and glucocorticoids.
Immunol Cell Biol. 79:376–384. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Al-Hejjaj WK, Numan IT, Al-Sa’ad RZ and
Hussain SA: Anti-inflammatory activity of telmisartan in rat models
of experimentally-induced chronic inflammation: Comparative study
with dexamethasone. Saudi Pharm J. 19:29–34. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Terzic N, Vujcic M, Ristic-Fira A,
Krstic-Demonacos M, Milanovic D, Kanazir DT and Ruzdijic S: Effects
of age and dexamethasone treatment on glucocorticoid response
element and activating protein-1 binding activity in rat brain. J
Gerontol A Biol Sci Med Sci. 58:297–303. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kumar RK, Herbert C, Thomas PS, et al:
Inhibition of inflammation and remodeling by roflumilast and
dexamethasone in murine chronic asthma. J Pharmacol Exp Ther.
307:349–355. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Smoak KA and Cidlowski JA: Mechanisms of
glucocorticoid receptor signaling during inflammation. Mech Ageing
Dev. 125:697–706. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Baschant U and Tuckermann J: The role of
the glucocorticoid receptor in inflammation and immunity. J Steroid
Biochem Mol Biol. 120:69–75. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bledsoe RK, Montana VG, Stanley TB, et al:
Crystal structure of the glucocorticoid receptor ligand binding
domain reveals a novel mode of receptor dimerization and
coactivator recognition. Cell. 110:93–105. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nicolaides NC, Galata Z, Kino T, Chrousos
GP and Charmandari E: The human glucocorticoid receptor: molecular
basis of biologic function. Steroids. 75:1–12. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schoneveld OJ, Gaemers IC and Lamers WH:
Mechanisms of glucocorticoid signalling. Biochim Biophys Acta.
1680:114–128. 2004. View Article : Google Scholar
|
|
15
|
Nissen RM and Yamamoto KR: The
glucocorticoid receptor inhibits NFkappaB by interfering with
serine-2 phosphorylation of the RNA polymerase II carboxy-terminal
domain. Genes Dev. 14:2314–2329. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schäcke H, Berger M, Rehwinkel H and
Asadullah K: Selective glucocorticoid receptor agonists (SEGRAs):
novel ligands with an improved therapeutic index. Mol Cell
Endocrinol. 275:109–117. 2007.PubMed/NCBI
|
|
17
|
Rosen J and Miner JN: The search for safer
glucocorticoid receptor ligands. Endocr Rev. 26:452–464. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Clark AR and Belvisi MG: Maps and legends:
the quest for dissociated ligands of the glucocorticoid receptor.
Pharmacol Ther. 134:54–67. 2012. View Article : Google Scholar : PubMed/NCBI
|
